Kefzol


Also found in: Dictionary.
Related to Kefzol: Ancef

Kefzol

A brand name for CEPHAZOLIN (cefazolin).
References in periodicals archive ?
The fifth product was the compound cefazolin, sold by Lilly under the name Kefzol. The identical compound was also sold by SmithKline under the name Ancef.
Lilly entered the market with Kefzol in November 1973.
The Revised CSP was designed to persuade hospitals to purchase Kefzol rather than Ancef.
Looking at market volumes in 1975, Lilly's market dollar volumes on Keflin, Keflex, and Kefzol were:
Keflin $33.97 million Keflex $13.834 million Kefzol $8.355 million (45) The other two cephalosporins accounted for $1.45 million in annual sales.
Consider the marginal cost of buying Kefzol. The hospital knows that it has to spend $340,000 buying Keflin and $138,000 buying Keflex ($478,000 in total), as these are supplied only by Lilly.
Prior to the introduction of the Revised CSP, Lilly's pretax return on sales for Kefzol was 17.6%.
The 20% effective discount it offered on Kefzol for buying its cephalosporin package was more than enough to eliminate any profits on this product and thus made it impossible for SmithKline to compete.
The drug on which there was competition, Kefzol, was also a substitute for Keflin.
Thus it was especially important for Lilly to prevent competition between SmithKline's Ancef and Lilly's Kefzol from damaging the golden goose of Keflin.
The 3% rebate on Keflin and Keflex contributed 17% of the 20% effective rebate on Kefzol. But that rebate came as a lump-sum amount.
(50) I note that a truly sophisticated hospital buying agent would recognize that the package discount of 20% on Kefzol would decline to a 3% discount (in the extreme) if Kefzol replaced all the other cephalosporins.